ArticleBioMed research international2022

ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer.

Meiwen Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.